Stock listing

Munich:CBHD Coloplast A/S Aktie

German listing (Munich) of Coloplast A/S · home listing Copenhagen:COLOB

Follow Coloplast A/S into a list and get an email when it puts out news.

Home listing price · OMXCOP:COLO_B

495.40 DKK -6.80 (-1.4%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXCOP:COLO_B

Past year -14.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
495.40 – 507.00 DKKNov 20, 2026
Volume
362,032 sharesNov 20, 2026
Market cap
102.7B DKKAt the close on Nov 20, 2026 · price × 207.4M shares outstanding
52-week range
369.70 – 590.40 DKKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
175.9M DKKMedian day 322,031 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Coloplast A/S logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Xetra:CBHD€65.86 EUR-0.66 (-1.0%)477€67.36€67.56€65.64€66.52Close on Nov 20, 2026
OTC:CLPBY$7.19 USD-0.09 (-1.2%)11,981$7.31$7.35$7.19$7.28Close on Nov 20, 2026
OTC:CLPBF$74.45 USD-0.87 (-1.2%)32$74.45$74.45$74.45$75.32Close on Nov 20, 2026
Frankfurt:CBHD€66.30 EUR-0.34 (-0.5%)—€66.00€66.40€66.00€66.64Close on Nov 20, 2026
Stuttgart:CBHD€66.08 EUR0.00 (0.0%)82€66.02€67.78€66.02€66.08Close on Nov 20, 2026
Frankfurt:CBH€6.45 EUR-0.15 (-2.3%)—€6.45€6.45€6.45€6.60Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXCOP:COLO_B · DKK, adjusted for splits

DayCloseChange%OpenHighLowVolume
495.40-6.80-1.4%503.00507.00495.40362,032
502.20-5.80-1.1%505.20512.60502.20250,827
508.00-2.20-0.4%511.00512.20501.60459,083
510.20+2.20+0.4%509.40512.20507.20303,818
508.00+13.90+2.8%496.50508.00494.10297,506
494.10+0.90+0.2%500.40503.80491.40244,407
493.20+4.10+0.8%490.00494.80485.20228,104
489.10-19.10-3.8%499.20503.40486.30524,402
508.20-17.20-3.3%512.40516.00498.90882,480
525.40+2.60+0.5%527.40530.00514.80617,588
522.80+27.10+5.5%489.10522.80485.70831,310
495.70+14.30+3.0%449.90495.70447.001,122,083
481.40-0.90-0.2%478.10486.80475.40366,034
482.30+5.30+1.1%483.00487.90480.40474,132
477.00-1.50-0.3%479.50483.80473.20322,031
478.50+1.00+0.2%476.50478.70471.50255,141
477.50-2.90-0.6%475.50477.50470.40324,110
480.40-4.30-0.9%485.00485.50477.70308,560
484.70+5.60+1.2%478.00484.70475.60245,499
479.10+9.70+2.1%471.70479.10470.00371,082
469.40-6.60-1.4%473.40475.40468.90288,585
476.00+9.10+1.9%472.00477.00471.30290,070
466.90-5.30-1.1%467.70472.70465.00212,046
472.20+3.70+0.8%465.00473.10462.30268,492
468.50+13.20+2.9%462.00468.50455.90377,924
455.30-0.60-0.1%459.00461.60453.90261,605
455.90+9.60+2.2%451.00461.20450.20441,637
446.30+10.40+2.4%438.10446.80436.00293,894
435.90+11.40+2.7%428.00439.40428.00311,870
424.50-1.80-0.4%426.30428.30421.30424,172
426.30+7.50+1.8%416.00427.00412.50649,516
418.80+8.80+2.1%414.20423.20413.40407,344
410.00-2.50-0.6%410.90413.30404.10558,081
412.50-2.80-0.7%413.60415.30410.60357,668
415.30-2.60-0.6%417.00421.10407.60304,634
417.90-1.10-0.3%422.90424.20417.90334,274
419.00-1.80-0.4%418.10423.30414.80279,690
420.80+3.20+0.8%421.20423.80415.60323,630
417.60-3.00-0.7%422.80424.00411.90362,766
420.60+1.00+0.2%420.40424.90417.10282,768
419.60-0.90-0.2%421.00422.10415.40254,150
420.500.000.0%422.50423.90415.30314,066
420.50+2.10+0.5%418.40420.60413.80261,146
418.40-1.70-0.4%419.90423.00417.60628,560
420.10+0.70+0.2%421.90422.60415.30282,431
419.40-0.30-0.1%420.30422.40416.30240,656
419.70+0.50+0.1%419.40422.60416.00197,505
419.20+3.10+0.7%420.00426.40419.00288,478
416.10-16.70-3.9%433.10433.10416.10388,614
432.80+0.80+0.2%431.20437.50430.30229,430
432.00-14.70-3.3%435.00437.40427.80433,170
446.70-6.10-1.3%453.80458.30446.70287,035
452.80-1.90-0.4%454.00454.70445.20204,629
454.70-9.20-2.0%466.00467.70454.60254,925
463.90-15.20-3.2%477.60479.10463.90357,684
479.10+9.70+2.1%474.10483.50467.10680,857
469.40+10.60+2.3%456.80475.50456.80781,113
458.80-3.90-0.8%461.30463.90456.20385,763
462.70+3.70+0.8%459.00467.80459.00328,664
459.00+4.80+1.1%451.80459.00447.30321,125
454.20-9.30-2.0%461.00461.00453.50324,618
463.50+1.00+0.2%456.20464.00453.00501,485
462.50+23.90+5.4%440.00462.50438.40560,982
438.60+2.80+0.6%432.90438.60429.80201,355
435.80-8.00-1.8%444.80444.80433.00256,698

Splits

6 splits since 1993 · OMXCOP:COLO_B · every price before a split is adjusted for it

DayRatioWhat
5-for-1Split
2-for-1Split
2-for-1Split
3-for-2Split
3-for-2Split
5-for-1Split
Ticker
Munich:CBHD
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Munich
Currency
EUR

What changed lately

Latest news

All Coloplast A/S news

Coloplast A/S on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
12 in the last 12 months · 23 in all · newest Sep 24, 2026 · oldest 2025
Calls
11 calls with a replay · 11 with a transcript · latest Aug 18, 2026
Decks
209 decks · latest Aug 18, 2026

Where Coloplast A/S is listed

ListingExchangeCountryCurrency
Copenhagen:COLOB · Home listingCopenhagenDenmarkDKK
Xetra:CBHDXetraGermanyEUR
LSIN:0QBOLSINUnited KingdomDKK
OTC:CLPBYOTCUnited StatesUSD
gettex:CBHDgettexGermanyEUR
VIE:COLOViennaAustriaEUR
Tradegate:CBHDTradegateGermanyEUR
OTC:CLPBFOTCUnited StatesUSD
Aquis:COLOBCAquisUnited KingdomDKK
Frankfurt:CBHDFrankfurtGermanyEUR
gettex:CBHgettexGermanyEUR
LS Exchange:A1KAGCLS ExchangeGermanyEUR
Lang & Schwarz:A1KAGCLang & SchwarzGermanyEUR
Stuttgart:CBHDStuttgartGermanyEUR
BX Swiss:CBHDBX SwissSwitzerlandCHF
Turquoise:COLOBCTurquoiseUnited KingdomDKK
Dusseldorf:CBHDDusseldorfGermanyEUR
Aquis:COLOBCAquisUnited KingdomDKK
BMV:0QBONBMVMexicoMXN
Hanover:CBHDHanoverGermanyEUR
Hamburg:CBHDHamburgGermanyEUR
Munich:CBHMunichGermanyEUR
Munich:CBHD · This pageMunichGermanyEUR
BIVA:0QBONBIVAMexicoMXN
Dusseldorf:CBHDusseldorfGermanyEUR
Frankfurt:CBHFrankfurtGermanyEUR

Valuation

P/E 33.4× against a median of 40.4×: 5th lowest of 10 Medical devices & supplies companies shown. Statements: Year to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
123.7B DKK
P/E
33.4×
EV/sales
4.3×
EV/EBITDA
10.5×
Price/book
7.2×
Gross margin
66.5%
Operating margin
25.4%
Net margin
10.6%
Debt to equity
1.5×
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Coloplast A/S Class B · OMXCOP:COLO_BUS$15.08BUS$18.16B33.4×4.3×10.5×7.2×10.6%1.5×n/a
Sonova Holding AG · SIX:SOONUS$20.69BUS$21.87B40.4×5.1×19.6×6.7×11.9%0.7×n/a
Straumann Holding AG · SIX:STMNUS$20.27BUS$20.39B47.8×6.6×24.6×7.5×13.7%0.2×n/a
Zimmer Biomet Holdings, Inc. · NYSE:ZBHUS$19.13BUS$26.24B24.9×3.1×11.6×1.5×8.9%0.6×0.40
Shanghai United Imaging Healthcare Co., Ltd. Class A · SSE:688271US$14.48BUS$13.77B54.1×5.9×n/a4.4×11.5%0.1×n/a
Solventum Corporation · NYSE:SOLVUS$14.36BUS$18.98B92.1×2.3×20.0×3.0×1.9%1.1×0.56
Baxter International Inc. · NYSE:BAXUS$13.14BUS$12.00Bn/a1.0×16.2×2.0×−6.2%0.1×0.97
Penumbra, Inc. · NYSE:PENUS$12.58BUS$11.90B80.1×7.6×n/a7.9×10.1%0.0×0.18
Smith & Nephew plc · LSE:SN.US$12.54BUS$15.58B20.1×2.5×11.4×2.4×10.1%0.7×n/a
The Cooper Companies, Inc. · NASDAQ:COOUS$11.20BUS$13.59B19.6×3.2×14.6×1.3×13.5%0.3×0.50
Align Technology, Inc. · NASDAQ:ALGNUS$11.02BUS$9.88B22.4×2.4×11.5×2.6×11.8%0.0×1.26
Median of the othersUS$13.75BUS$14.68B40.4×3.1×15.4×2.8×10.8%0.3×0.53

Forecasts

Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.

Price target
473.81 DKK · Analysts' mean
EPS, year to Sep 2027
24.99 · 20 analysts
Revenue, year to Sep 2027
31.21B · 19 analysts

Team and board

Officers

OfficerRole
Gavin WoodPresident & CEO of Coloplast
Anders Lonning-SkovgaardExecutive Vice President, CFO
Julie Sommer MügglerCoordinator & PA, Investor Relations
Kristine Husted MunkSenior Director, Investor Relations
Nicklas OvergaardSenior Manager, Investor Relations
Simone Dyrby HelvindSr. Manager, Investor Relations
Allan RasmussenExecutive Vice President, Global Operations
Amanda RajkumarExecutive Vice President, Chief People Officer
Caroline Vagner RosenstandExecutive Vice President, Chronic Care Commercial
Kevin HardageExecutive Vice President, Interventional Urology
Rasmus JustExecutive Vice President, Chronic Care R&D
Thomas BarfodSenior Controller and member of the Coloplast Board

Board

DirectorRole
Jette Nygaard-AndersenInterim Chair of the Board

Events

Next results
Feb 9, 2027 (expected)

Calls

CallWhenStatus
Coloplast (Copenhagen:COLO B) Q3 2026 Earnings CallTue, Aug 18, 2026 · 5:00 AM ETReplay
Coloplast (Copenhagen:COLO B) Q2 2026 Earnings CallTue, May 12, 2026 · 5:00 AM ETReplay
Coloplast (Copenhagen:COLO B) Q1 2026 Earnings CallFri, Feb 06, 2026 · 12:00 PM ETReplay
Coloplast (Copenhagen:COLO B) Q4 2025 Earnings CallTue, Nov 04, 2025 · 7:00 AM ETReplay
Coloplast (Copenhagen:COLO B) Q3 2025 Earnings CallTue, Aug 19, 2025 · 5:00 AM ETReplay
Coloplast (Copenhagen:COLO B) Q2 2025 Earnings CallTue, May 06, 2025 · 5:00 AM ETReplay
Coloplast (Copenhagen:COLO B) Q1 2025 Earnings CallTue, Feb 04, 2025 · 5:00 AM ETReplay
Coloplast (Copenhagen:COLO B) Q4 2024 Earnings CallTue, Nov 05, 2024 · 5:00 AM ETReplay
Coloplast (Copenhagen:COLO B) Q3 2024 Earnings CallTue, Aug 20, 2024 · 5:00 AM ETReplay
Coloplast (Copenhagen:COLO B) Q2 2024 Earnings CallTue, May 07, 2024 · 3:00 AM ETReplay
All 11 calls
CallWhenStatus
Coloplast (Copenhagen:COLO B) Q1 2024 Earnings CallFri, Feb 09, 2024 · 5:00 AM ETReplay

Results days

QuarterResultsShare move
Q4 2026Nov 3, 2026 · After close+5.5%
Q3 2026Aug 18, 2026 · Before open+3.0%
Q2 2026May 12, 2026 · Before open+1.6%
Q1 2026Feb 6, 2026 · Before open−8.2%
Q4 2025Nov 4, 2025 · Before open+4.8%
Q3 2025Aug 19, 2025 · Before open−1.2%
Q2 2025May 6, 2025 · Before open−6.0%
Q1 2025Feb 4, 2025 · Before open−2.4%
Q4 2024Nov 5, 2024 · Before open−0.3%
Q3 2024Aug 20, 2024 · Before open−5.0%
All 20 quarters
QuarterResultsShare move
Q2 2024May 7, 2024 · Before open−3.5%
Q1 2024Feb 9, 2024 · Before open+9.7%
Q4 2023Nov 9, 2023 · Before open−6.9%
Q3 2023Aug 17, 2023 · Before open−2.6%
Q2 2023May 11, 2023 · Before open−4.3%
Q1 2023Feb 3, 2023 · Before open−1.7%
Q4 2022Nov 7, 2022 · Before open−2.1%
Q3 2022Aug 17, 2022 · Before open+7.3%
Q2 2022May 5, 2022 · Before open−5.5%
Q1 2022Jan 25, 2022 · Before open+0.8%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings10 slidesAug 18, 2026
9M 2025/26 Earnings PresentationEarnings99 slidesAugust 2026
Non-Deal Roadshow (May 2026)Roadshow98 slidesMay 2026
Q1 2025/26 Earnings PresentationEarnings9 slidesFeb 6, 2026
Q1 2025/26 Earnings PresentationEarnings94 slidesFebruary 2026
Q1 2025/26 Earnings PresentationEarnings95 slidesFebruary 2026
Q2 2025/26 Earnings PresentationEarnings4 slides2026
Shareholder Meeting (December 2025)Shareholder meeting37 slidesDecember 2025
FY 2024/25 Earnings PresentationEarnings10 slidesNov 4, 2025
Non-Deal Roadshow (November 2025)Roadshow97 slidesNovember 2025
Show 50 decks
DeckKindSlidesDate
Investor Day (September 2025)Investor day118 slidesSep 2, 2025
Q3 2025 Earnings PresentationEarnings11 slidesAug 19, 2025
Non-Deal Roadshow (August 2025)Roadshow95 slidesAugust 2025
H1 2024/25 Earnings PresentationEarnings11 slidesMay 6, 2025
H1 2024/25 Earnings PresentationEarnings99 slidesMay 2025
Q1 2025 Earnings PresentationEarnings9 slidesFeb 4, 2025
Non-Deal Roadshow (February 2025)Roadshow94 slidesFebruary 2025
H1 2025/26 Earnings PresentationEarnings10 slides2025
Shareholder Meeting (December 2024)Shareholder meeting36 slidesDecember 2024
FY 2023/24 Earnings PresentationEarnings100 slidesNov 5, 2024
Q3 2024 Earnings PresentationEarnings9 slidesAug 20, 2024
Non-Deal Roadshow (August 2024)Roadshow101 slidesAugust 2024
H1 2023/24 Earnings PresentationEarnings11 slidesMay 7, 2024
Non-Deal Roadshow (May 2024)Roadshow101 slidesMay 2024
Q1 2023/24 Earnings PresentationEarnings96 slidesFebruary 2024
FY2023/24 Earnings PresentationEarnings11 slides2024
Shareholder Meeting (December 2023)Shareholder meeting43 slidesDec 6, 2023
Non-Deal Roadshow (November 2023)Roadshow102 slidesNovember 2023
Merger or Acquisition (September 2023)Merger or acquisition10 slidesSep 4, 2023
Non-Deal Roadshow (August 2023)Roadshow108 slidesAugust 2023
Merger or Acquisition (July 2023)Merger or acquisition11 slidesJul 7, 2023
H1 2022/23 Earnings PresentationEarnings101 slidesMay 2023
Q1 2022/23 Earnings PresentationEarnings96 slidesFebruary 2023
FY2022/23 Earnings PresentationEarnings12 slides2023
H1 2022/23 Earnings PresentationEarnings10 slides2023
Q1 2023/24 Earnings PresentationEarnings10 slides2023
Non-Deal Roadshow (November 2022)Roadshow100 slidesNovember 2022
Non-Deal Roadshow (August 2022)Roadshow91 slidesAugust 2022
Non-Deal Roadshow (May 2022)Roadshow92 slidesMay 2022
ESG Presentation (March 2022)Sustainability60 slidesMar 22, 2022
Q1 2021/22 Earnings PresentationEarnings9 slidesFebruary 2022
9M 2022/23 Earnings PresentationEarnings9 slides2022
Q1 2021/22 Earnings PresentationEarnings84 slidesJanuary 2022
9M 2021/22 Earnings PresentationEarnings9 slides2022
H1 2021/22 Earnings PresentationEarnings10 slides2022
FY2021/22 Earnings PresentationEarnings12 slides2022
Q1 2022/23 Earnings PresentationEarnings10 slides2022
Non-Deal Roadshow (November 2021)Roadshow81 slidesNovember 2021
ESG Presentation (March 2021)Sustainability16 slidesMarch 2021
Q1 2020/21 Earnings PresentationEarnings76 slidesFebruary 2021

This page holds 50 of 209 decks. Open Decks

Open Decks

Financials

Annual, in DKK

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue28.9B27.9B27.0B24.5B22.6B19.4B18.5B17.9B16.4B15.5B
Cost of revenue9.70B8.93B8.76B8.17B7.05B6.11B5.93B5.79B5.38B4.96B
Gross profit19.2B18.9B18.3B16.3B15.5B13.3B12.6B12.2B11.1B10.6B
Research and development1.07B946.0M913.0M872.0M866.0M755.0M708.0M692.0M640.0M574.0M
Selling, general and administrative10.8B1.24B1.11B1.00B762.0M762.0M757.0M653.0M623.0M
Operating income7.36B7.20B7.32B6.77B6.44B6.36B5.85B5.16B5.09B5.02B
Depreciation and amortization4.43B863.0M839.0M1.07B930.0M792.0M851.0M651.0M625.0M611.0M
EBITDA11.8B8.06B8.16B7.84B7.37B7.15B6.71B5.81B5.72B5.63B
Interest expense747.0M1.15B1.10B719.0M240.0M57.0M63.0M54.0M44.0M45.0M
Income before tax3.85B6.16B6.39B6.03B6.13B6.23B5.47B5.03B5.01B4.95B
Income tax775.0M2.52B1.34B1.24B1.42B1.41B1.27B1.16B1.16B1.15B
Net income3.07B3.64B5.05B4.78B4.71B4.83B4.20B3.87B3.85B3.80B
Earnings per share, basic13.6416.1322.4622.1922.1122.6319.6818.1718.1017.87
Earnings per share, diluted16.1322.46

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents511.0M947.0M788.0M911.0M414.0M448.0M323.0M356.0M297.0M314.0M
Short-term investments-39.0M219.0M226.0M262.0M313.0M310.0M315.0M
Receivables5.00B4.66B4.67B4.59B4.32B3.44B3.27B3.35B3.07B3.15B
Inventory4.06B3.92B3.67B3.52B3.19B2.43B2.23B1.93B1.73B1.69B
Current assets9.95B10.5B10.4B9.94B8.77B6.99B6.49B6.36B5.59B6.19B
Property, plant and equipment6.20B5.65B4.13B3.58B3.16B2.84B2.90B2.69B
Goodwill16.5B19.3B19.4B20.0B11.8B2.03B1.98B2.03B1.98B1.72B
Total assets46.3B48.4B48.1B48.2B35.0B15.8B13.5B12.7B11.8B12.1B
Accounts payable1.70B1.32B1.52B1.29B1.24B1.04B814.0M859.0M751.0M675.0M
Current liabilities13.5B6.50B10.2B16.3B7.34B6.31B4.98B4.94B4.71B5.42B
Long-term debt13.6B19.4B16.6B11.6B16.4B0
Total debt21.5B22.6B22.6B19.6B18.7B2.79B1.75B1.21B1.36B1.46B
Total liabilities32.0B32.2B30.1B30.9B26.7B7.67B6.09B5.82B5.35B6.10B
Shareholders' equity14.3B16.1B17.9B17.3B8.29B8.17B7.41B6.91B6.42B5.95B
Shares outstanding225.4M225.4M224.9M215.5M212.8M213.2M213.3M213.1M212.4M212.5M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations8.01B6.64B2.77B4.23B5.10B5.29B4.76B4.36B4.36B3.25B
Capital spending-1.39B-1.31B-1.17B-1.24B-1.14B-1.97B-931.0M-636.0M-669.0M-685.0M
Free cash flow6.62B5.34B1.60B2.98B3.96B3.32B3.83B3.72B3.69B2.57B
Cash from investing-1.73B-1.25B-1.34B-8.96B-11.8B-2.01B-901.0M-591.0M-947.0M-1.62B
Cash from financing-6.75B-5.19B-1.52B5.26B6.59B-3.18B-3.86B-3.71B-3.43B-1.86B
Dividends paid-5.18B-4.96B-4.72B-4.25B-4.04B-3.83B-3.61B-3.40B-3.29B-2.86B
Share buybacks0-619.0M-500.0M-500.0M-500.0M-500.0M-500.0M
Change in cash-436.0M207.0M-88.0M534.0M-34.0M125.0M-33.0M59.0M-17.0M-241.0M

Open Financials

Cap table

Built by 6ix from Coloplast A/S Class B’s releases

Common shares
207,368,138
Fully diluted
207,368,138

Fully diluted

LineShares
Common shares207,368,138

Share count over time

CountShares
Nov 22, 2026207,368,138

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
Rhumbline Advisers147KUS$931KSep 30, 2026
GAMMA Investing LLC28,317US$179KSep 30, 2026
PNC Financial Services Group, Inc.4,305US$27,208Sep 30, 2026

Funds

HolderSharesValueAs of
MFS International Intrinsic Value Fund3.01MUS$186MMay 31, 2026
Vanguard Total International Stock Index Fund1.97MUS$131MJul 31, 2026
Vanguard Developed Markets Index Fund1.31MUS$74.5MJun 30, 2026
BNY Mellon International Stock Fund916KUS$56.6MMay 31, 2026
iShares Core MSCI EAFE ETF890KUS$58.9MJul 31, 2026
Janus Henderson Global Equity Income Fund555KUS$31.7MJun 30, 2026
Fidelity International Index Fund474KUS$29.1MMay 31, 2026
Baird Chautauqua International Growth Fund446KUS$25.4MJun 30, 2026
iShares MSCI EAFE ETF435KUS$28.8MJul 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund322KUS$21.3MJul 31, 2026
Show 50 holders
HolderSharesValueAs of
Vanguard European Stock Index Fund321KUS$21.2MJul 31, 2026
Bridge Builder International Equity Fund318KUS$18.1MJun 30, 2026
Schwab International Equity ETF300KUS$18.6MMay 31, 2026
Mercer Non-US Core Equity Fund272KUS$15.5MJun 30, 2026
Siit World Equity Ex-Us Fund256KUS$15.7MMay 31, 2026
Fidelity Series Global ex U.S. Index Fund248KUS$16.4MJul 31, 2026
Harbor International Fund233KUS$15.4MJul 31, 2026
MFS International Intrinsic Value Portfolio227KUS$12.9MJun 30, 2026
EQ/MFS International Intrinsic Value Portfolio222KUS$12.7MJun 30, 2026
Nuveen International Equity Index Fund212KUS$14MJul 31, 2026
iShares MSCI EAFE Growth ETF194KUS$12.8MJul 31, 2026
Strategic Advisers International Fund168KUS$10.3MMay 31, 2026
Vanguard International High Dividend Yield Index Fund161KUS$10.7MJul 31, 2026
iShares Core MSCI Total International Stock ETF160KUS$10.6MJul 31, 2026
ALPS International Sector Dividend Dogs ETF148KUS$9.17MMay 31, 2026
FlexShares International Quality Dividend Index Fund135KUS$8.94MJul 31, 2026
T. Rowe Price European Stock Fund133KUS$8.79MJul 31, 2026
Bridge Builder Tax Managed International Equity Fund126KUS$7.15MJun 30, 2026
iShares MSCI EAFE Min Vol Factor ETF126KUS$8.3MJul 31, 2026
Calvert International Equity Fund123KUS$7.02MJun 30, 2026
iShares Core MSCI International Developed Markets ETF118KUS$7.83MJul 31, 2026
Victory Market Neutral Income Fund117KUS$6.66MJun 30, 2026
BBH Partner Fund - International Equity115KUS$7.57MJul 31, 2026
International Core Equity 2 Portfolio114KUS$7.57MJul 31, 2026
Vanguard Total World Stock Index Fund111KUS$7.33MJul 31, 2026
Empower International Value Fund109KUS$6.22MJun 30, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF103KUS$5.86MJun 30, 2026
Lazard International Quality Growth Portfolio99,596US$5.68MJun 30, 2026
JPMorgan BetaBuilders Europe ETF96,613US$6.39MJul 31, 2026
Multi-Manager International Equity Strategies Fund95,200US$5.84MMay 31, 2026
Baird Chautauqua Global Growth Fund90,468US$5.15MJun 30, 2026
Schwab International Index Fund84,552US$5.59MJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account82,682US$4.71MJun 30, 2026
Variable Portfolio - Partners International Growth Fund78,800US$4.49MJun 30, 2026
iShares MSCI EAFE International Index Fund78,304US$4.46MJun 30, 2026
Fidelity Total International Index Fund75,092US$4.97MJul 31, 2026
Empower International Growth Fund74,620US$4.25MJun 30, 2026
iShares MSCI Intl Quality Factor ETF71,646US$4.74MJul 31, 2026
iShares Core MSCI Europe ETF68,190US$4.51MJul 31, 2026
JNL/Lazard International Quality Growth Fund67,810US$4.61MMar 31, 2026

This page holds 50 of 248 holders. Open Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Allan RasmussenExecutive Vice President, Global Operations · Since at least Jun 3, 2025
Amanda RajkumarExecutive Vice President, Chief People Officer · Since at least Nov 5, 2026
Anders Lonning-SkovgaardExecutive Vice President, CFO · Since at least Sep 24, 2026
Caroline Vagner RosenstandExecutive Vice President, Chronic Care Commercial · Since at least Aug 19, 2025
Gavin WoodPresident & CEO of Coloplast · Since May 1, 2026
Jette Nygaard-AndersenInterim Chair of the Board · Since at least Mar 4, 2026
Julie Sommer MügglerCoordinator & PA, Investor Relations · Since at least Apr 22, 2026
Kevin HardageExecutive Vice President, Interventional Urology · Since at least Dec 18, 2025
Kristine Husted MunkSenior Director, Investor Relations · Since at least Sep 24, 2026
Nicklas OvergaardSenior Manager, Investor Relations · Since at least Sep 24, 2026
All 13 people
PersonSeat
Rasmus JustExecutive Vice President, Chronic Care R&D · Since at least Aug 19, 2025
Simone Dyrby HelvindSr. Manager, Investor Relations · Since at least May 12, 2026
Thomas BarfodSenior Controller and member of the Coloplast Board · Since at least Dec 4, 2025

Open People

Log in to ask 6ix AI your own questions about Coloplast A/S.